United States Federal Circuit

In patent infringement suit involving a combination eye-drop product used for treating glaucoma, the district court's findings that plaintiff's patent claims are not invalid, are: 1) reversed in part, where the district court erred in finding the claims of the '463 patent not invalid as obvious; 2) affirmed in part, where defendants, failed to prove by clear and convincing evidence that claim 4 of the '149 patent would have been obvious; and 3) affirmed in part, where there was no error in the district court's claim construction.

Appellate Information

• Decided 05/01/2013
• Published 05/01/2013

Judges

• PROST

Court

• United States Federal Circuit

Counsel